Impressive Continuous Complete Response after Mogamulizumab in a Heavily Pretreated Sézary Syndrome Patient

BACKGROUND: Sézary syndrome (SS) is a rare lymphoproliferative neoplasm, almost incurable outside the setting of allogeneic transplantable patients. The prognosis for relapsed/refractory patients remains poor, as the available drugs confer short-lasting remission. In this setting, the anti-chemokine...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mediterr J Hematol Infect Dis
Autori principali: Lolli, Ginevra, Casadei, Beatrice, Argnani, Lisa, Nanni, Laura, Cavo, Michele, Zinzani, Pier Luigi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Università Cattolica del Sacro Cuore 2020
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340218/
https://ncbi.nlm.nih.gov/pubmed/32670518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2020.040
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi